FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | EvidenceVariable |
| Id | EvidenceVariable-236950.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: EvidenceVariable 236950
version: 73; Last updated: 2025-10-07 17:12:54+0000; Language: en
Profile: GroupAssignment
url: https://fevir.net/resources/EvidenceVariable/236950
identifier: FEvIR Object Identifier/236950, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-group-assignment-85394-85798
name: GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA
title: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA
citeAs:
GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236950. Revised 2025-10-07. Available at: https://fevir.net/resources/EvidenceVariable/236950. Computable resource at: https://fevir.net/resources/EvidenceVariable/236950#json.
status: Active
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Type | Target[x] |
| Part Of | MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) |
| Concept |
| Defined in handling and category elements |
handling: dichotomous variable
category
name: SGLT2 inhibitors
value: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors
category
name: GLP-1 RA
{
"resourceType": "EvidenceVariable",
"id": "236950",
"meta": {
"versionId": "73",
"lastUpdated": "2025-10-07T17:12:54.639Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
]
},
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://fevir.net/resources/EvidenceVariable/236950",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "236950",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "MAGIC-5288-j1Wqrn-group-assignment-85394-85798",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA",
"title": "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA",
"citeAs": "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236950. Revised 2025-10-07. Available at: https://fevir.net/resources/EvidenceVariable/236950. Computable resource at: https://fevir.net/resources/EvidenceVariable/236950#json.",
"status": "active",
"author": [
{
"name": "Computable Publishing®: MAGIC-to-FEvIR Converter"
}
],
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"relatesTo": [
{
"type": "part-of",
"targetReference": {
"type": "Composition",
"identifier": {
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "MAGIC-5288-j1Wqrn-conversion-report",
"assigner": {
"display": "Computable Publishing LLC"
}
},
"display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
}
}
],
"definition": {
"concept": {
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "defined-in-handling-and-category",
"display": "Defined in handling and category elements"
}
]
}
},
"handling": "dichotomous",
"category": [
{
"name": "SGLT2 inhibitors",
"valueReference": {
"reference": "Group/236769",
"type": "Group",
"identifier": {
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "MAGIC-5288-j1Wqrn-intervention-85394-I-85798",
"assigner": {
"display": "Computable Publishing LLC"
}
},
"display": "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors"
}
},
{
"name": "GLP-1 RA",
"valueReference": {
"reference": "Group/236776",
"type": "Group",
"identifier": {
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "MAGIC-5288-j1Wqrn-comparator-85394-C-85798",
"assigner": {
"display": "Computable Publishing LLC"
}
},
"display": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists"
}
}
]
}